Authors: Catalyurek, H.¹; Oktay, G.²; Guzeloglu, M.¹; Çavdar, Z.²; Acikel, U.¹; Silistreli, E.¹; Hazan, E.¹

Source: The Journal of International Medical Research, Volume 36, Number 3, May 2008 , pp. 551-558(8)

Publisher: Field House Publishing

Abstract:

Reperfusion of myocardium during coronary bypass activates matrix metalloproteinases (MMPs) with changes occurring in the levels of tissue inhibitors of metalloproteinases (TIMPs) in the myocardium. This study investigated the effects of insulin-blood cardioplegia on MMP activity and TIMP levels during reperfusion. Non-diabetic patients undergoing coronary artery bypass graft with cardiopulmonary bypass were randomized into a control group (n = 12) or an insulin group (n = 12). Blood cardioplegia was used for both groups; insulin and glucose were added to the insulin group. Blood samples were obtained from the coronary sinus just before aortic cross clamping and after 1 and 30 min of reperfusion. Plasma proenzyme MMPs (proMMP-2 and -9) and TIMPs (TIMP-1 and TIMP-2) levels were measured. There were no differences between groups for MMP-2 and TIMP-2 levels. However, insulin diminished proMMP-9 activation, although some still occurred. TIMP-1 consumption lessened during reperfusion which, we conclude, was as a result of the diminished MMP activation. This is the first open heart surgery study in which diminished MMP activation was achieved via a metabolic change.

References: 29 references open in new window

Articles that cite this article?

Keywords: REPERFUSION INJURY; CORONARY ARTERY BYPASS GRAFT (CABG); CARDIOPULMONARY BYPASS (CPB); MATRIX METALLOPROTEINASES; TISSUE INHIBITORS OF METALLOPROTEINASES

Document Type: Research article

Affiliations: 1: Department of Cardiovascular Surgery, Dokuz Eylül University Medical School, Balcova, Izmir, Turkey 2: Department of Biochemistry, Dokuz Eylül University Medical School, Balcova, Izmir, Turkey

Publication date: 2008-05-01

More about this publication?

• The Journal of International Medical Research (JIMR) is a leading peer reviewed journal offering exceptional publication speed for medical, clinical and pre-clinical research. Reviews, case studies, preliminary communications, post-marketing surveillance, pharmacoeconomic and managed care studies are also welcome. Supplements publish symposium proceedings or collections of medical, pre-clinical or clinical data and enquiries from potential sponsors are welcome. JIMR is widely indexed and abstracted, including Medline, Current Contents and Excerpta Medica (EMBASE).
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Internal Medicine ,  Pharmacology ,  Public Health
• By this author: Catalyurek, H. ;  Oktay, G. ;  Guzeloglu, M. ;  Çavdar, Z. ;  Acikel, U. ;  Silistreli, E. ;  Hazan, E.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers